Диссертация (1140935), страница 33
Текст из файла (страница 33)
/ K. Okano, S. Wu, X. Huang, C.J. Pirola, H. Juppner, A.B. Abou-Samra[et al.] // Endocrinology. – 1994. – Vol. 135 (3). – P. 1093–1099.240.Olson, F.J. Circulating matrix metalloproteinase 9 levels in relation tosampling methods, femoral and carotid atherosclerosis. / F.J. Olson, C. Schmidt,A. Gummesson, V. Sigurdardottir, J.
Hulthe [et al.] // J. Intern. Med. – 2008. –Vol. 263. – P. 626–635.241.Olsson,J.ExpressionofneutrophilSOD2isreducedafterlipopolysaccharide stimulation: a potential cause of neutrophil dysfunction inchronic kidney disease / J. Olsson, T.A. Jacobson, J.M. Paulsson [et al.] //Nephrol. Dial. Transplant. – 2011. – Vol.
26, № 7. – P. 2195-2201.242.Ozdemir, F.N. Role of parathormone levels on T-cell response inhemodialysis patients. / F.N. Ozdemir, U. Yakupoglu, M. Turan [et al.] //Transplantation Proceedings. – 2002. – Vol. 34 (6). – P. 2044–2045.243.Pacifici, R. Role of T cells in the modulation of PTH action: physiologicaland clinical significance. / Pacifici R. // Endocrine.
– 2013. - Vol. 44 (3). – P.576-582. - doi: 10.1007/s12020-013-9960-8.244.Packard, R.R. Inflammation in atherosclerosis: from vascular biology tobiomarker discovery and risk prediction. / R.R. Packard, P. Libby // Clin. Chem.– 2008. – Vol. 54. – P. 24–38.245.Pahl, M.V. Effect of end-stage renal disease on B-lymphocytesubpopulations, IL-7, BAFF and BAFF receptor expression / M.V. Pahl, S.Gollapudi, L.
Sepassi [et al.] // Nephrol Dial Transplant. – 2010. – Vol. 25. – Р.205-212.246.Panaroni, C. Interactions between B lymphocytes and the osteoblast lineagein bone marrow. / C. Panaroni, J.Y. Wu // Calcif. Tissue Int. – 2013. – Vol. 93(3). – P. 261-268.247.Peng, Hu. Fibroblast Growth Factor-23 Helps Explain the BiphasicCardiovascular Effects of Vitamin D in Chronic Kidney Disease / Hu.
Peng, X.200Qiang, Hu. Bo, Lu. Ling, W. Jing, H. Q. Yuan // Int. J. Biol. Sci. – 2012. – Vol.8(5). P. 663–671.248.Perry, H.M. III, Parathyroid hormone receptors in circulating humanmononuclear leukocytes. / H.M. Perry, III, J.C. Chappel, E. Bellorin-Font, J.Tamao, K.J. Martin, S.L. Teitelbaum // Journal of Biological Chemistry. – 1984.– Vol. 259 (9). – P. 5531–5535.249.Pinheiro, P.L. Functional characterization and evolution of PTH/PTHrPreceptors: insights from the chicken. / P.L.
Pinheiro, J.C. Cardoso, D.M.Power, A.V. Canário. // BMC Evol. Biol. – 2012. – Vol. 12. – P. 110. - doi:10.1186/1471-2148-12-110.250.Pistoia, V. Production of cytokines by human B cells in health and disease./ V. Pistoia // Immunol. Today. – 1997. – Vol. 18. – P.
343–350.251.Pitt, S.C. Secondary and tertiary hyperparathyroidism: the utility of ioPTHmonitoring. / S.C. Pitt, R. Panneerselvan, H. Chen [et al.] // World J. Surg. –2010. – Vol. 34(6). – P. 1343–1349.252.Porsti, I.H. Expanding targets of vitamin D receptor activation:downregulation of several RAS components in the kidney. / I.H. Porsti // KidneyInt. – 2008. – Vol. 74, № 11. – P. 1371–1373.253.Quarles, L.D. Role of FGF23 in vitamin D and phosphate metabolism:implications in chronic kidney disease.
/ L.D. Quarles // Exp. Cell. Res. – 2012. –Vol. 318 (9). – P.1040-1048.254.Raggatt, L.J. Interleukin-18 is regulated by parathyroid hormone and isrequired for its bone anabolic actions. / L.J.Raggatt, L. Qin, J. Tamasi, S.C.Jefcoat, Jr, E. Shimizu [et al.] // J. Biol. Chem.
– 2008. – Vol. 283 – P. 6790–6798.255.Rambausek, M. Vascular effects of parathyroid hormone (PTH). / M.Rambausek, E. Ritz, W. Rascher, W. Kreusser, J.F. Mann, V.A. Kreye [et al.] //Adv. Exp. Med. Biol. – 1982. – Vol. 151. – P. 619-632.256.Rautenberg, P. Influenza subtype-specific IgA, IgM and IgG responses inpatients on hemodialysis after influenza vaccination.
/ P. Rautenberg, I. Teifke, T.201Schlegelberger, U. Ullmann // Infection. – 1988. – Vol. 16 (6). – P. 323–328.257.Remuzzi, G. Parathyroid hormone inhibits human platelet function. / G.Remuzzi, A. Benigni, P. Dodesini, A. Schieppati, M. Livio, E. Poletti [et al.]// Lancet. – 1982. – Vol 11. – P. 1321–1324.258.Remschmidt, C. Influenza vaccination in patients with end-stage renaldisease: systematic review and assessment of quality of evidence related tovaccine efficacy, effectiveness, and safety.
/ C. Remschmidt , O. Wichmann, T.Harder // BMC Med. – 2014. – Vol. 12: 244. doi: 10.1186/s12916-014-0244-9.Review.259.Riancho, J.A. Vitamin D therapy modulates cytokine secretion in patientswith renal failure / J.A. Riancho, M.T. Zarrabeitia, A.L. de Francisco [et al.] //J.Nephron. – 1993. – Vol. 65. – Р. 364-368.260.Riccardi, D. Physiology and pathophysiology of the calcium-sensingreceptor in the kidney.
/ D. Riccardi, E.M. Brown // Am. J. Physiol. Renal.Physiol. – 2010. Vol. 298, № 3. – P. F485–F499.261.Romero, J.R. Parathyroid hormone ablation alters erythrocyte parametersthat are rescued by calcium-sensing receptor gene deletion. / J.R. Romero, R.Youte, E.M. Brown, M.R. Pollak, D. Goltzman, A. Karaplis, L.C. Pong, L.Chien, N. Chattopadhyay, A.
Rivera // Eur. J. Haematol. – 2013. – Vol. 91 (1). –P. 37-45.262.Rosol, T.J. Pathophysiology of calcium metabolism. / T.J. Rosol, D.J.Chew, L.A. Nagode, C.C. Capen // Vet. Clin. Pathol. 1995. – Vol. 24, № 2. – P.49–63.263.Rubin, M.R. Arterial stiffness in mild primary hyperparathyroidism. /M.R. Rubin, M.S.
Maurer, D.J. McMahon, J.P. Bilezikian, S.J. Silverberg // J.Clin. Endocrinol. Metab. – 2005. – Vol. 90, - P. 3326–3330.264.Russo, D. Clinical significance of FGF-23 in patients with CKD. / D.Russo, Y. Battaglia // Int. J. Nephrol. – 2011. – Vol. 2011. - P. 364891–364895.265.Ryckman, C. Proinflammatory activities of S100: proteins S100A8,S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. / C.202Ryckman, K. Vandal, P. Rouleau, M. Talbot, P.A.Tessier // J.
Immunol. – 2003. –Vol. 170. – P. 3233–3242.266.Saini, V. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor(PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responsesto PTH. / V. Saini, D.A. Marengi , K.J. Barry [et al.] // J. Biol. Chem. – 2013.
–Vol. 288 (28). – P. 20122-20134.267.Saito, M. Increase in cell-surface localization of parathyroid hormonereceptor by cytoskeletal protein 4.1G. / M. Saito, M. Sugai, Y. Katsushima, T.Yanagisawa, J. Sukegawa, N. Nakahata // The Biochemical journal. – 2005. –Vol. 392 (Pt 1). – P. 75–81.268.Salomon, P. Influence of amlodipine on serum level of some cytokines inpatients with congestive heart failure. / P.
Salomon, B. Halawa, B. Karolko // Pol.Arch. Med. Wewn. – 2003. – Vol. 109 (2). – P. 149-155.269.Santos, L.S. Surgical reduction of the renal mass in rats: morphologic andfunctional analysis on the remnant kidney / L.S. Santos, E.W. Chin, S.O. Ioshii[et al.] // Acta Cir Bras. – 2006. – Vol. 21, №4. – Р.
252-257.270.Sardenberg,C.Effectsofuraemiaanddialysismodalityonpolymorphonuclear cell apoptosis and function. / C. Sardenberg, P. Suassuna,M.C.C. Andreoli [et al.] // Nephrol. Dial. Transplant. – 2006. – Vol. 21. – P. 160–165.271.Sebastian, E.M. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renalfailure. / E.M. Sebastian, L.J. Suva, P.A. Friedman // Bone. – 2008. – Vol. 43 (6).–P.
1022-1030.272.Seyrek, N. Amlodipine prevents and reverses the elevation in [Ca2+](i) andthe impaired phagocytosis of PMNL of diabetic rats. / N. Seyrek, W.Marcinkowski, M. Smogorzewski, T.M. Demerdash, S.G. Massry. // NephrologyDialysis Transplantation. – 1997. – Vol. 12 (2). – P. 265–272.273.Shasha, S.M. Effect of parathyroidectomy on T cell functions in patientswith primary hyperparathyroidism.
/ S.M. Shasha, B. Kristal, O. Steinberg, T.203Shkolnik. American Journal of Nephrology. 1989. – Vol. 9 (1). – P. 25–29.274.Shasha, S.M. In vitro effect of PTH on normal T cell functions. / S.M.Shasha, B. Kristal, M. Barzilai, U.E. Makov, T. Shkolnik // Nephron. – 1988. –Vol. 50 (3). – P. 212–216.275.Shen, L. Parathyroid hormone versus bisphosphonate treatment on bonemineral density in osteoporosis therapy: a meta-analysis of randomized controlledtrials.
/ L. Shen, X. Xie, Y. Su, C. Luo, C. Zhang, B. Zeng // PLoS One. – 2011. –Vol. 6(10). – P. e26267. doi: 10.1371/journal.pone.0026267. Epub. 2011, Oct 12.276.Schenck, P.A. Disorders of calcium: hypercalcemia and hypocalcemia. /P.A. Schenck, D.J. Chew, L.A. Nagode, S.P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
